* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Jukic et al. SUPPLEMANTARY SUPLEMENTARY METHODS En1+/
Endocannabinoid system wikipedia , lookup
Neurotransmitter wikipedia , lookup
Activity-dependent plasticity wikipedia , lookup
Single-unit recording wikipedia , lookup
Multielectrode array wikipedia , lookup
Neurogenomics wikipedia , lookup
Biological neuron model wikipedia , lookup
Caridoid escape reaction wikipedia , lookup
Neural coding wikipedia , lookup
Electrophysiology wikipedia , lookup
Mirror neuron wikipedia , lookup
Metastability in the brain wikipedia , lookup
Circumventricular organs wikipedia , lookup
Neuroeconomics wikipedia , lookup
Neural oscillation wikipedia , lookup
Neuroanatomy wikipedia , lookup
Neural correlates of consciousness wikipedia , lookup
Development of the nervous system wikipedia , lookup
Central pattern generator wikipedia , lookup
Nervous system network models wikipedia , lookup
Premovement neuronal activity wikipedia , lookup
Feature detection (nervous system) wikipedia , lookup
Synaptic gating wikipedia , lookup
Pre-Bötzinger complex wikipedia , lookup
Clinical neurochemistry wikipedia , lookup
Channelrhodopsin wikipedia , lookup
Jukic et al. SUPPLEMANTARY SUPLEMENTARY METHODS En1+/Otx2 mutants The generation and genotyping of En1+/Otx2 mice has been reported earlier (Broccoli, et al 1999; Brodski, et al 2003). Mutants were kept on a CD-1 genetic background. For lithium and carbamazepine repetitive OFT experiments mutants were backcrossed for 6 generations to a Black Swiss genetic background. Mice were kept in a temperature-controlled (21–22 °C) room under reversed 12 h light/dark cycle (lights were turned off at 10:00 a.m.), with free access to food and water. After weaning, animals were kept as groups of 4-6 in a cage. All experiments were performed on 3-6 months old males, which were single caged one week prior to any behavioral test. OFT, EPM, LDB, and social interaction tests were all conducted between 12:00 and 17:00 in the separate behavior testing room. Mice were transferred to the behavior testing room 30 min prior to the beginning of the above mentioned behavioral tests in order to habituate to the new environment. In case that the same animals were used repetitively in more than one behavioral test (Supplementary figure 2a, d, e), tests were conducted from the least invasive to the most invasive test: OFT, LDB, and EPM with at least 72 h break between the tests (Flaisher-Grinberg and Einat, 2010). Home cage locomotor activity Prior to the testing, animals were anesthetized with an intraperitoneal injection of a ketamine-xylazine mixture (100 mg/kg and 10 mg/kg, respectively) and chronically 1 Jukic et al. implanted with DSI TA-F10 telemetry probes. The transmitter was able to freely move among the peritoneal organs because it was not attached to the peritoneum. After ten days of recovery, locomotor activity of animals was recorded and analyzed with DSI DataQuest ART 4.3 software. Locomotor activity (counts) was obtained by counting the number of impulses, detected by changes in signal strength, per time unit. The signal was received by an antenna under each animal’s cage and transferred to a peripheral processor connected to a personal computer. All transmitters were calibrated before surgery and at the completion of experimentation to ensure the validity of biotelemetry measurements. Locomotor activity was calculated as an hourly or daily average of the raw data, collected at 1 s intervals by counting the number of impulses, detected by changes signal strength. (Tarasiuk, et al 2014). Open Field Test Mice were placed in the open fields made of Plexiglas and measuring 40 x 40 x 30 cm under red light. The box was cleaned with a dilute ethanol solution (10%) between trials and carefully dried. For locomotor activity, animals were videotaped and recordings were analyzed off-line using Noldus EthoVision® 9 program. In order to define the center/periphery exploration, we defined the center zone in Noldus Ethovision® 9 program (20 x 20 cm). In order to study intra-session habituation of En1+/Otx2 mice in more detail, we quantified the level of activity change ratios (ACR). Values derived with the formula ACR=b/(a+b), were computed for each trial of each individual mice as described previously (Bothe, et al 2004; Leussis and Bolivar 2006). In this formula a is the activity during the first 5 minutes, and b is the averaged value of the 5 min intervals after 15 minutes of habituation. Values below 2 Jukic et al. 0.5 indicate a decrease, values above 0.5 indicate an increase and values closely around 0.5 indicate no changes in activity over time. Light-Dark Box The experiments were conducted in a well-lit behavioral testing room. The Plexiglas apparatus was constructed from a 13 x 40 x 30 cm dark compartment closed with a lid and a 27 x 40 x 30 cm light compartment. Those two were joined by a 5 x 5 cm opening in the wall between them. The apparatus was cleaned with a dilute ethanol solution (10%) between trials and carefully dried. Mice were placed in the light compartment, videotaped for 10 min, and recordings were analyzed off-line using the Noldus EthoVision® 9 program. Elevated Plus Maze The experiments were conducted in a well-lit behavioral testing room. The apparatus was constructed out of transparent Plexiglas and consisted of two opposing open arms and two perpendicular opposing closed arms. The arms were 50 cm in length and 5 cm wide. The closed arms had walls that were 40 cm high, whereas the open arms had a half cm ledge to prevent falling. The EPM was wiped clean with a dilute ethanol solution (10%) between trials and carefully dried. At the start of the trial, the mouse was placed in the center of the maze, facing a closed arm and videotaped for 5 min. The number of entries and time spent in each of the arms were analyzed off line using the Noldus Ethovision® 9 program. We measured the number of entries and the time spent in the open arms as a percentage of the total number of entries and the time spent in all arms. 3 Jukic et al. Chronic sucrose preference Prior to the experiment animals were exposed for two weeks to two bottles of tap water. During the following 6 weeks animals received a choice between water and a 2% or 5% sucrose solution and sucrose preference was calculated for the last four weeks according to the weekly protocol. Every week, mice were given access to two drinking bottles positioned one next to the other. Twenty-four hour fluid consumption was measured by daily weighing the bottles during the last hour before the onset of the dark phase (9:00-10:00 AM). All interaction with the animals was conducted during this period. Sucrose solution (2% and 5% prepared in tap water) was placed in one bottle and the tap water in the other. In order to study fluctuations in sucrose preference over time, we designed a one week protocol according to a previously described method (Taliaz, et al 2011). For day one and two of the week, the sucrose solution was placed on the left side of the cage and water on the right. On day three of the week, only tap water was administered on both sides and all animals were weighed. On day four and five the sucrose solution and water were placed in reverse to control for side preference. On day six and seven of the week animals received two tap water bottles. Sucrose preference for each mouse was defined as the average percentage of sucrose consumption of the total liquid consumption. Sucrose and total liquid intake were calculated by normalizing the volume of consumed sucrose solution or total liquid intake with the animal weight for that week. Only day two and day five were included in the analysis. This procedure was repeated for six weeks, out of which the first two weeks represent the adjustment period and were not taken into the analysis. Social interaction test 4 Jukic et al. Two mice of the same age, weight and genotype were placed in the opposite corners of the open-field under the red light as previously described (Shaltiel, et al 2008). Their activities were videotaped for 5 min, and the time spent in social activity was manually scored using the Noldus EthoVision® program. The open field was wiped clean between trials with a 10% alcohol solution. Acute (IP) injections Quipazine maleate (5mg/kg, purchased from Sigma-Aldrich Israel) and CP-809101 (5mg/kg, purchased from Tocris Bioscience) were both dissolved in saline and injected IP into test animals 15 minutes prior to behavioral tests. These doses were chosen to robustly increase serotonin receptor activation in the brain as previously described (Hutchinson, et al 2012; Kaur and Kulkarni 2002; Siuciak, et al 2007). Olanzapine (purchased from Sigma-Aldrich Israel) was dissolved in 0.1 M HCl, diluted with water, and titrated with 0.1 M NaOH towards neutrality (pH higher than 5) without any precipitation. Vehicle and olanzapine solutions (1 mg/kg) were injected IP into test animals one hour before behavioral tests. This protocol was chosen according to the previously reported anti-manic effect in mice (Engel, et al, 2010). Animals were tested in the OFT, LDB, and EPM in this order for the animals treated with olanzapine (figures S4, 3a, b) and quipazine (figure 4a, b), with a distinct cohort used for each drug. Established wash-out periods of 14 days were used between repetitive acute IP injections followed by behavioral tests (Mattiuz et al, 1997; Valencia-Flores et al, 1990). The sequence of the tests was conducted from the least invasive to the most invasive test (Flaisher-Grinberg and Einat, 2010). Chronic lithium and carbamazepine treatment 5 Jukic et al. Lithium carbonate and carbamazepine (purchased from Sigma-Adrich Israel) were mixed into powdered food. For the lithium experiments, an additional bottle of saline was added to each cage in order to compensate for the electrolyte loss in lithium treated animals. After one week of food containing 0.12% lithium, lithium concentrations were raised to 0.24%, for four weeks before the start and throughout the testing (Einat, et al 2003). After the experiment lithium serum concentrations were measured and only animals having lithium levels in the therapeutic range (0.51.2 mEq/l) were included in the analysis. Six OFTs were conducted during a period of three weeks. For carbamazepine treatment mice received for one week powdered food containing carbamazepine at a concentration of 0.25%. Two weeks before the start and throughout the testing, carbamazepine concentrations in the food were 0.5% as previously suggested (Kara, et al 2014). Four OFTs were conducted during a period of two weeks. Statistical analysis: All results are expressed as mean ± SE. IBM® SPSS® Statistics 21 software was used for the statistical analysis. A two-tailed unpaired Student's t-test was used for the comparative analyses. For the experiments that included pharmacological treatment, in addition to genotype, treatment effect was analyzed as a factor for twoway multifactorial analysis of variance (ANOVA test). Where significant effects were detected, Fisher’s LSD post hoc analysis indicated significant differences between individual groups. INRICH Pathway analysis 6 Jukic et al. 1. Compilation of gene lists: Lists of genes specifying DA and 5HT neurons were compiled in a two-step process. In the first step, a http://www.ncbi.nlm.nih.gov/pubmed search was performed using the search terms “dopamine and development”, “dopamine and embryo”, as well as “serotonin and development” and “serotonin and embryo”, including studies published up until May 2014. In a second step, the published studies obtained from this search were screened according to the following criteria: 1. Studies performed in vivo 2. Studies performed in mammals 3. Studies related to midbrain dopaminergic or rostral serotonergic neurons. 4. Studies related to the specification of monoaminergic neurons. We choose these criteria according to the following rationales. 1: In vitro studies are not necessarily relevant in vivo (Hegarthy et al., 2013). 2: Only experiments performed in mammals were considered, since pathways for monoaminergic neuronal specification in non-mammals differ substantially from mammalian pathways (Hegarthy et al., 2013). 3. Only data relevant for midbrain DA or rostral 5HT sub-populations were considered, since they are affected in En1+/Otx2 mutants and relevant to psychiatric disorders. In contrast, other DA and 5HT subpopulations, not affected in En1+/Otx2 mutants, e.g. olfactory DA or caudal hindbrain 5HT neurons projecting to the spinal cord, are less likely to be involved in these disorders. 4. Since En1+/Otx2 mutants exhibit alterations in the specification of monoaminergic neurons rather than in their migration or projection (Brodski, et al 2003), only studies that report this aspect of development were taken into consideration. Based on these publications a gene list was compiled for DA as well as for 5-HT neurons. 7 Jukic et al. 2. INRICH Analysis In order to test if the sequence variants of selected gene sets are correlated with psychiatric disorders we used INRICH, an interval-based enrichment analysis tool for GWAS (Lee, et al 2012). INRICH evaluates each target set by considering the number of intervals that contain at least one target gene sequence. The data used for the statistical analysis was obtained from the metaanalysis study of bipolar disorders conducted by the Psychiatric Genomics Consortium (PGC) (Psychiatric GWAS Consortium Bipolar Disorder Working Group 2011). Associated LD-independent genomic intervals were based on the LD pruned SNP dataset downloaded from PGC website (http://pgc.unc.edu) on 10.11.2013 for each disease (Supplementary files: pgc.bip.clump for BPD, pgc.scz.clump for SCZ, and pgc.mdd.clump for MDD). Intervals were spanning 250kbp up/downstream on variants attaining statistical significance for relationships at P≤0.001. We defined gene regions as 100 kb up/downstream of the transcription starting/ending sites for all genes on autosomal chromosomes based on the ENTREZ gene map hg 18 (Maglott, et al 2005) downloaded from the INRICH website (atgu.mgh.harvard.edu/inrich/downloads.html) on 10.11.2013 (Supplementary file entrez.gene.map). Significance was assessed through 100,000 permutations in which randomly selected genomic regions matched for gene and SNP density were compared with the target interval set. In order to test whether there is a degree of correspondence between the test intervals and the target sets, we calculated global enrichment. It indicates whether more targets than expected by chance are within one of the associated intervals and within at least one set that is nominally significant at P≤0.01. Finally, resampling-based 10000 second-step permutation was conducted in order to adjust the empirical P-values for testing multiple candidate target sets. 8 Jukic et al. Since we repeatedly tested the hypothesis that sequence variants of genes directing the development of DA neurons are associated with BPD using different data sets, we corrected for multiple testing. We used the p-values obtained from the INRICH analysis using the lists of genes directing the specification of dopaminergic neurons compiled by us and by Hegarthy et al, for the FDR correction, according to SanGiovanni and Lee, 2013. 9 Jukic et al. TABLE 1 REFERENCES Alberi L, Sgado P, Simon HH (2004). Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons. Development 131: 3229-3236. Alves dos Santos MT and Smidt MP (2011). En1 and Wnt signaling in midbrain dopaminergic neuronal development. Neural Dev 6: 23-8104-6-23. Andersson E, Jensen JB, Parmar M, Guillemot F, Bjorklund A (2006a). Development of the mesencephalic dopaminergic neuron system is compromised in the absence of neurogenin 2. Development 133: 507-516. Andersson E, Tryggvason U, Deng Q, Friling S, Alekseenko Z, Robert B, Perlmann T, Ericson J (2006b). Identification of intrinsic determinants of midbrain dopamine neurons. Cell 124: 393-405. Andersson ER, Prakash N, Cajanek L, Minina E, Bryja V, Bryjova L, Yamaguchi TP, Hall AC, Wurst W, Arenas E (2008). Wnt5a regulates ventral midbrain morphogenesis and the development of A9-A10 dopaminergic cells in vivo. PLoS One 3: e3517. Baquet ZC, Bickford PC, Jones KR (2005). Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta. J Neurosci 25: 6251-6259. Blum M (1998). A null mutation in TGF-alpha leads to a reduction in midbrain dopaminergic neurons in the substantia nigra. Nat Neurosci 1: 374-377. Briscoe J, Sussel L, Serup P, Hartigan-O'Connor D, Jessell TM, Rubenstein JL, Ericson J (1999). Homeobox gene Nkx2.2 and specification of neuronal identity by graded Sonic hedgehog signalling. Nature 398: 622-627. 10 Jukic et al. Brodski C, Weisenhorn DM, Signore M, Sillaber I, Oesterheld M, Broccoli V, Acampora D, Simeone A, Wurst W (2003). Location and size of dopaminergic and serotonergic cell populations are controlled by the position of the midbrain-hindbrain organizer. J Neurosci 23: 4199-4207. Chakrabarty K, Von Oerthel L, Hellemons A, Clotman F, Espana A, Groot Koerkamp M, Holstege FC, Pasterkamp RJ, Smidt MP (2012). Genome wide expression profiling of the mesodiencephalic region identifies novel factors involved in early and late dopaminergic development. Biol Open 1: 693-704. Craven SE, Lim KC, Ye W, Engel JD, de Sauvage F, Rosenthal A (2004). Gata2 specifies serotonergic neurons downstream of sonic hedgehog. Development 131: 1165-1173. Deng Q, Andersson E, Hedlund E, Alekseenko Z, Coppola E, Panman L, Millonig JH, Brunet JF, Ericson J, Perlmann T (2011). Specific and integrated roles of Lmx1a, Lmx1b and Phox2a in ventral midbrain development. Development 138: 3399-3408. Ding YQ, Marklund U, Yuan W, Yin J, Wegman L, Ericson J, Deneris E, Johnson RL, Chen ZF (2003). Lmx1b is essential for the development of serotonergic neurons. Nat Neurosci 6: 933-938. Dudok JJ, Groffen AJ, Toonen RF, Verhage M (2011). Deletion of Munc18-1 in 5-HT neurons results in rapid degeneration of the 5-HT system and early postnatal lethality. PLoS One 6: e28137 Ellisor D, Rieser C, Voelcker B, Machan JT, Zervas M (2012). Genetic dissection of midbrain dopamine neuron development in vivo. Dev Biol 372: 249-262. 11 Jukic et al. Ferri AL, Lin W, Mavromatakis YE, Wang JC, Sasaki H, Whitsett JA, Ang SL (2007). Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner. Development 134: 2761-2769. Fox SR and Deneris ES (2012). Engrailed is required in maturing serotonin neurons to regulate the cytoarchitecture and survival of the dorsal raphe nucleus. J Neurosci 32: 7832-7842. Hendricks TJ, Fyodorov DV, Wegman LJ, Lelutiu NB, Pehek EA, Yamamoto B, Silver J, Weeber EJ, Sweatt JD, Deneris ES (2003). Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxietylike and aggressive behavior. Neuron 37: 233-247. Hoekstra EJ, von Oerthel L, van der Heide LP, Kouwenhoven WM, Veenvliet JV, Wever I, Jin YR, Yoon JK, van der Linden AJ, Holstege FC, Groot Koerkamp MJ, Smidt MP (2013). Lmx1a encodes a rostral set of mesodiencephalic dopaminergic neurons marked by the Wnt/B-catenin signaling activator Rspondin 2. PLoS One 8: e74049. Hoekstra EJ, von Oerthel L, van der Linden AJ, Smidt MP (2012). Phox2b influences the development of a caudal dopaminergic subset. PLoS One 7: e52118. Hynes M, Poulsen K, Tessier-Lavigne M, Rosenthal A (1995). Control of neuronal diversity by the floor plate: contact-mediated induction of midbrain dopaminergic neurons. Cell 80: 95-101. Hynes M, Stone DM, Dowd M, Pitts-Meek S, Goddard A, Gurney A, Rosenthal A (1997). Control of cell pattern in the neural tube by the zinc finger transcription factor and oncogene Gli-1. Neuron 19: 15-26. 12 Jukic et al. Hynes M, Ye W, Wang K, Stone D, Murone M, Sauvage F, Rosenthal A (2000a). The seven-transmembrane receptor smoothened cell-autonomously induces multiple ventral cell types. Nat Neurosci 3: 41-46. Hynes M, Ye W, Wang K, Stone D, Murone M, Sauvage F, Rosenthal A (2000b). The seven-transmembrane receptor smoothened cell-autonomously induces multiple ventral cell types. Nat Neurosci 3: 41-46. Iwakura Y, Wang R, Abe Y, Piao YS, Shishido Y, Higashiyama S, Takei N, Nawa H (2011). Dopamine-dependent ectodomain shedding and release of epidermal growth factor in developing striatum: target-derived neurotrophic signaling (Part 2). J Neurochem 118: 57-68. Jacob J, Ferri AL, Milton C, Prin F, Pla P, Lin W, Gavalas A, Ang SL, Briscoe J (2007). Transcriptional repression coordinates the temporal switch from motor to serotonergic neurogenesis. Nat Neurosci 10: 1433-1439. Jacob J, Storm R, Castro DS, Milton C, Pla P, Guillemot F, Birchmeier C, Briscoe J (2009). Insm1 (IA-1) is an essential component of the regulatory network that specifies monoaminergic neuronal phenotypes in the vertebrate hindbrain. Development 136: 2477-2485. Joksimovic M, Yun BA, Kittappa R, Anderegg AM, Chang WW, Taketo MM, McKay RD, Awatramani RB (2009). Wnt antagonism of Shh facilitates midbrain floor plate neurogenesis. Nat Neurosci 12: 125-131. Kele J, Simplicio N, Ferri AL, Mira H, Guillemot F, Arenas E, Ang SL (2006). Neurogenin 2 is required for the development of ventral midbrain dopaminergic neurons. Development 133: 495-505. Kholodilov N, Yarygina O, Oo TF, Zhang H, Sulzer D, Dauer W, Burke RE (2004). Regulation of the development of mesencephalic dopaminergic systems by 13 Jukic et al. the selective expression of glial cell line-derived neurotrophic factor in their targets. J Neurosci 24: 3136-3146. Lahti L, Peltopuro P, Piepponen TP, Partanen J (2012). Cell-autonomous FGF signaling regulates anteroposterior patterning and neuronal differentiation in the mesodiencephalic dopaminergic progenitor domain. Development 139: 894-905. Matise MP, Epstein DJ, Park HL, Platt KA, Joyner AL (1998a). Gli2 is required for induction of floor plate and adjacent cells, but not most ventral neurons in the mouse central nervous system. Development 125: 2759-2770. Matise MP, Epstein DJ, Park HL, Platt KA, Joyner AL (1998b). Gli2 is required for induction of floor plate and adjacent cells, but not most ventral neurons in the mouse central nervous system. Development 125: 2759-2770. Ono Y, Nakatani T, Minaki Y, Kumai M (2010). The basic helix-loop-helix transcription factor Nato3 controls neurogenic activity in mesencephalic floor plate cells. Development 137: 1897-1906. Omodei D, Acampora D, Mancuso P, Prakash N, Di Giovannantonio LG, Wurst W, Simeone A (2008). Anterior-posterior graded response to Otx2 controls proliferation and differentiation of dopaminergic progenitors in the ventral mesencephalon. Development. 135: 3459-70 Osterberg N, Wiehle M, Oehlke O, Heidrich S, Xu C, Fan CM, Krieglstein K, Roussa E (2011). Sim1 is a novel regulator in the differentiation of mouse dorsal raphe serotonergic neurons. PLoS One 6: e19239. Pattyn A, Simplicio N, van Doorninck JH, Goridis C, Guillemot F, Brunet JF (2004). Ascl1/Mash1 is required for the development of central serotonergic neurons. Nat Neurosci 7: 589-595. 14 Jukic et al. Pattyn A, Vallstedt A, Dias JM, Samad OA, Krumlauf R, Rijli FM, Brunet JF, Ericson J (2003). Coordinated temporal and spatial control of motor neuron and serotonergic neuron generation from a common pool of CNS progenitors. Genes Dev 17: 729-737. Prakash N, Brodski C, Naserke T, Puelles E, Gogoi R, Hall A, Panhuysen M, Echevarria D, Sussel L, Weisenhorn DM, Martinez S, Arenas E, Simeone A, Wurst W (2006). A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo. Development 133: 89-98. Rabe TI, Griesel G, Blanke S, Kispert A, Leitges M, van der Zwaag B, Burbach JP, Varoqueaux F, Mansouri A (2012). The transcription factor Uncx4.1 acts in a short window of midbrain dopaminergic neuron differentiation. Neural Dev 7: 39-8104-7-39. Ratzka A, Baron O, Stachowiak MK, Grothe C (2012). Fibroblast growth factor 2 regulates dopaminergic neuron development in vivo. J Neurochem 122: 94105. Ribeiro D, Ellwanger K, Glagow D, Theofilopoulos S, Corsini NS, Martin-Villalba A, Niehrs C, Arenas E (2011). Dkk1 regulates ventral midbrain dopaminergic differentiation and morphogenesis. PLoS One 6: e15786. Sakane F and Miyamoto Y (2013). N-cadherin regulates the proliferation and differentiation of ventral midbrain dopaminergic progenitors. Dev Neurobiol 73: 518-529. Simon HH, Saueressig H, Wurst W, Goulding MD, O'Leary DD (2001). Fate of midbrain dopaminergic neurons controlled by the engrailed genes. J Neurosci 21: 3126-3134. 15 Jukic et al. Simon HH, Scholz C, O'Leary DD (2005). Engrailed genes control developmental fate of serotonergic and noradrenergic neurons in mid- and hindbrain in a gene dose-dependent manner. Mol Cell Neurosci 28: 96-105. Smidt MP, Asbreuk CH, Cox JJ, Chen H, Johnson RL, Burbach JP (2000). A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. Nat Neurosci 3: 337-341. Smidt MP, Smits SM, Bouwmeester H, Hamers FP, van der Linden AJ, Hellemons AJ, Graw J, Burbach JP (2004). Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3. Development 131: 1145-1155. Sousa KM, Villaescusa JC, Cajanek L, Ondr JK, Castelo-Branco G, Hofstra W, Bryja V, Palmberg C, Bergman T, Wainwright B, Lang RA, Arenas E (2010). Wnt2 regulates progenitor proliferation in the developing ventral midbrain. J Biol Chem 285: 7246-7253. Tang M, Villaescusa JC, Luo SX, Guitarte C, Lei S, Miyamoto Y, Taketo MM, Arenas E, Huang EJ (2010). Interactions of Wnt/beta-catenin signaling and sonic hedgehog regulate the neurogenesis of ventral midbrain dopamine neurons. J Neurosci 30: 9280-9291. van Doorninck JH, van Der Wees J, Karis A, Goedknegt E, Engel JD, Coesmans M, Rutteman M, Grosveld F, De Zeeuw CI (1999). GATA-3 is involved in the development of serotonergic neurons in the caudal raphe nuclei. J Neurosci 19: RC12. Zetterstrom RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann T (1997). Dopamine neuron agenesis in Nurr1-deficient mice. Science 276: 248-250. 16 Jukic et al. SUPPLEMENTARY FIGURE 1 En1+/Otx2 mutants show increased spontaneous fluctuations in their locomotor activity in their home cage under constant darkness After five days in the normal light/dark cycle, the animal activity was recorded daily for 33 days under constant darkness, normalized to the average activity level of that animal during the entire period, and shown as a function of day in separate plots for each of the nine (a) WT and eleven (b) En1+/Otx2 mutant animals. (c) En1+/Otx2 mutants showed increased intra-individual fluctuation as indicated by an increased CV (t18=2.157, p=0.047). Two-tailed unpaired Student's t-test: *p<0.05 17 Jukic et al. SUPPLEMENTARY FIGURE 2 En1+/Otx2 mutants show increased levels of locomotor activity, risk taking behavior and reduced levels of hedonic-like and social behavior. (a) In the OFT, mutants were more active (t16=2.972, p=0.003) and entered more into the center than controls (t16=3.572, p=0.001), while the percentage of the distance traveled in the center did not significantly differ between genotypes (t16=0.997, p=0.452). (b) The time mutants spent in social interaction was decreased compared to the WTs (t16=2.945, p=0.011). (c) The sucrose preference in the mutant mice was lower compared to WTs (t18=3.459, p=0.003), while the sucrose (t18=0.631, p=0.536) and total liquid intake (t18=1.476, p=0.157) did not differ between genotypes. (d) In the EPM, mutants showed more entries into (t18=3.583, p=0.001) and time spent (t18=2.149, p=0.036) in the open arms compared to controls, while number of entries into all arms did not differ between groups (t18=0.684, p=0.497). Mutants spent significantly more time in the light compartment in the LDB than WTs (t18=5.149, p<0.001). Two-tailed unpaired Student's t-test: *p<0.05, **p<0.01, ***p<0.001 18 Jukic et al. SUPPLEMENTARY FIGURE 3 The activity of En1+/Otx2 mutants correlates with their risk-taking behavior and habituation, but not with their fluctuations in activity Locomotor activity, ACRs, the number of entries into and the percentage of distance traveled in the center of the OFT were analyzed for the 45 minute OFT for each animal. (a) The frequency of entries to the center correlated with activity levels for both mutants (r27=0.882, p<0.001) and controls (r29=0.772, p<0.001), while the distance traveled in the center correlated with activity levels only in En1+/Otx2 (r27=0.447, p=0.015) and not in WT animals (r29=0.089, p=0.633). (b) Activity levels and ACRs were correlated for both WTs (r28=0.699, p<0.001) and mutants (r27=0.661, p<0.001). (c) The activity of the animals was not correlated with the coefficients of variance for both the mutants (r27=0.187, p<0.418) and the controls (r27=0.015, p<0.953) in six repetitive one hour OFTs. 19 Jukic et al. SUPPLEMENTARY FIGURE 4 Olanzapine reduces activity and risk-taking behavior in both mutants and controls Vehicle and olanzapine solutions (1 mg/kg) were injected IP into animals one hour before they were tested in the OFT for 60 minutes. Olanzapine decreased the (a) activity (TreatmentF1,36=4.834, p=0.034) and the (b) number of entries into the center (TreatmentF1,36=8.092, p=0.007) of both WT and En1+/Otx2 mutants, without a differential effect on genotypes (Genotype*TreatmentF1,36=0.588, p=0.448; Genotype*TreatmentF 1,36=0.313, p=0.580). There was no significant interaction between the genotype and the treatment for the percentage of distance traveled in the center of the OFT (Genotype*TreatmentF1,36=1.023, p=0.319). (c) ACR was increased after the acute olanzapine treatment (TreatmentF1,36=6.829, p=0.013) with no selective effect to neither of the genotypes (Genotype*TreatmentF1,36=0.338, p=0.564). 20 Jukic et al. SUPPLEMENTARY FIGURE 5 En1+/Otx2 mutants maintained on a BS genetic background show increased fluctuations in their locomotor activity and risk-taking behavior En1+/Otx2 mutants were exposed to the repetitive OFT, the values for the distance traveled were normalized by the individual animal average, and were depicted by different colors for the each animal as the function of the trial. En1+/Otx2 mutants showed an increase in the CV in their activity levels in the repetitive OFT compared to WTs when maintained on the CD1 genetic background (t18=3.912, p=0.001) and on the BS genetic background (t18=4.143, p=0.001). The number of entries and the percentage of the distance (center vs total) traveled in the center was also measured in animals on both backgrounds. In contrast to (c) the CD1 genetic background where only number of entries into (t18=4.32, p<0.001) and not the percentage of distance traveled in the center (t18=0.648, p=0.52) was increased in mutants, (d) mutants on BS background entered more into (t18=4.939, p<0.001) and traveled more distance in the center (t18=7.537, p<0.001). Taken together, these results 21 Jukic et al. suggest that En1+/Otx2 mutants on a Black Swiss genetic background maintained the intra-individual differences observed on a CD-1 genetic background and that they showed a stronger manic-like phenotype in the OFT. Two-tailed unpaired Student's ttest: ***p<0.001 22 Jukic et al. SUPPLEMENTARY REFERENCES Bothe GW, Bolivar VJ, Vedder MJ, Geistfeld JG (2004). Genetic and behavioral differences among five inbred mouse strains commonly used in the production of transgenic and knockout mice. Genes Brain Behav 3: 149-157. Broccoli V, Boncinelli E, Wurst W (1999). The caudal limit of Otx2 expression positions the isthmic organizer. Nature 401: 164-168. Brodski C, Weisenhorn DM, Signore M, Sillaber I, Oesterheld M, Broccoli V, Acampora D, Simeone A, Wurst W (2003). Location and size of dopaminergic and serotonergic cell populations are controlled by the position of the midbrainhindbrain organizer. J Neurosci 23: 4199-4207. Einat H, Yuan P, Gould TD, Li J, Du J, Zhang L, Manji HK, Chen G (2003). The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 23: 7311-7316. Engel SR, Creson TK, Hao Y, Shen Y, Maeng S, Nekrasova T, Landreth GE, Manji HK, Chen G (2009). The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement. Mol Psychiatry 14: 448-461. Flaisher-Grinberg S, Einat H (2010) Strain-specific battery of tests for domains of mania: effects of valproate, lithium and imipramine. Front Psychiatry. 1: e00010 Hutchinson AN, Deng JV, Aryal DK, Wetsel WC, West AE (2012). Differential regulation of MeCP2 phosphorylation in the CNS by dopamine and serotonin. Neuropsychopharmacology 37: 321-337. Kara NZ, Karpel O, Toker L, Agam G, Belmaker RH, Einat H (2014). Chronic oral carbamazepine treatment elicits mood-stabilising effects in mice. Acta Neuropsychiatrica 26: 29-34. Kaur G and Kulkarni SK (2002). Evidence for serotonergic modulation of progesterone-induced hyperphagia, depression and algesia in female mice. Brain Res 943: 206-215. Lee PH, O'Dushlaine C, Thomas B, Purcell SM (2012). INRICH: interval-based enrichment analysis for genome-wide association studies. Bioinformatics 28: 1797-1799. Leussis MP and Bolivar VJ (2006). Habituation in rodents: a review of behavior, neurobiology, and genetics. Neurosci Biobehav Rev 30: 1045-1064. Mattiuz E, Franklin R, Gillespie T, Murphy A, Bernstein J, Chiu A, Hotten T, Kassahun K (1997) Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys. Drug Metab Dispos 25: 573-583 Maglott D, Ostell J, Pruitt KD, Tatusova T (2005). Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res 33: D54-8. Psychiatric GWAS Consortium Bipolar Disorder Working Group (2011). Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 43: 977-983. 23 Jukic et al. SanGiovanni JP, Lee PH. (2013) AMD-Associated Genes Encoding Stress-Activated MAPK Pathway Constituents Are Identified by Interval-Based Enrichment Analysis. PloS One 8: e71239 Shaltiel G, Maeng S, Malkesman O, Pearson B, Schloesser RJ, Tragon T, Rogawski M, Gasior M, Luckenbaugh D, Chen G, Manji HK (2008). Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania. Mol Psychiatry 13: 858-872. Siuciak JA, Chapin DS, McCarthy SA, Guanowsky V, Brown J, Chiang P, Marala R, Patterson T, Seymour PA, Swick A, Iredale PA (2007). CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity. Neuropharmacology 52: 279-290. Taliaz D, Loya A, Gersner R, Haramati S, Chen A, Zangen A (2011). Resilience to chronic stress is mediated by hippocampal brain-derived neurotrophic factor. J Neurosci 31: 4475-4483. Tarasiuk A, Levi A, Berdugo-Boura N, Yahalom A, Segev Y (2014). Role of Orexin in Respiratory and Sleep Homeostasis during Upper Airway Obstruction in Rats. Sleep 37: 978-998 Valencia-Flores M, Campos-Sepulveda E, Galindo-Morales JA, Lujan M, Colotla VA (1990). Behavioral and biochemical correlates of chronic administration of quipazine. Pharmacol Biochem Behav 36: 299-304. 24